News & Updates
Filter by Specialty:
Working out heightens sexual function in men with prostate cancer
Prostate cancer treatment upends sexual function in men, but the good news is that supervised resistance and aerobic workout can counter these sexual side effects, according to a study presented at ASCO Breakthrough 2023.
Working out heightens sexual function in men with prostate cancer
29 Aug 2023
Chemo-induced nausea, vomiting? There’s a dexamethasone-free regimen for that
A dexamethasone-free regimen helps improve control of nausea and vomiting in patients receiving “highly emetogenic” chemotherapy, with the antiemetic effect being superior to that of a dexamethasone-based regimen, according to the results of a phase III trial presented at ASCO Breakthrough 2023.
Chemo-induced nausea, vomiting? There’s a dexamethasone-free regimen for that
28 Aug 2023
QoL preserved in patients with refractory mCRC treated with add-on bevacizumab
In the treatment of refractory metastatic colorectal cancer (mCRC), the addition of bevacizumab to trifluridine/tipiracil (FTD/TPI) does not appear to hurt the quality of life (QoL), with patients receiving add-on bevacizumab being able to maintain their QoL for a longer period than those receiving FTD/TPI monotherapy, according to a post hoc analysis of the phase III SUNLIGHT trial.
QoL preserved in patients with refractory mCRC treated with add-on bevacizumab
26 Aug 2023
Older age at first screening colonoscopy linked to higher risk of adenomas, CRC
At a first screening colonoscopy, older patients are more likely to have a detection of adenomatous polyps and colorectal cancer (CRC), reveals a study.
